Lithuanian Medical Devices Translator & Copy Editor

Welo Global; United States; A distancia; USD 34.000 - 55.000; Jornada completa

Descripción de la vacante

Welo Life Sciences is seeking experienced English into Lithuanian linguists specializing in Medical Devices and In Vitro Diagnostics translation.

You will translate and copy edit regulatory documentation, ensure accurate terminology, and comply with project‑specific quality requirements. The role requires memoQ12.5 proficiency and adherence to ISO‑certified workflows. Ongoing weekly availability is expected.

Formación

• Degree in Translation or Linguistics, or an equivalent field, or a qualifying graduate degree plus translation experience.
• Minimum of two years full‑time professional translation experience in Life Sciences.
• At least five years of full‑time professional translation experience in Life Sciences preferred.

Responsabilidades

• Translate English (US) medical device and IVD documentation into Lithuanian accurately.
• Perform copy edit to ensure terminology consistency and quality compliance.
• Address QA and client feedback on linguistic issues.
• Meet deadlines and maintain high-quality standards.
• Work within MEMOQ12.5 or higher CAT tool environment with provided license.
• Follow project-specific instructions and workflows.

Conocimientos

Medical Devices

IVD translation

Copy Edit

Terminology management

Quality standards

memoQ proficiency

Life Sciences

CAT tools

Educación

Translation or Linguistics degree

Graduate qualification + 2 years translation

5+ years translation experience

Herramientas

memoQ 12.5+

Microsoft Word

Descripción del empleo

Welo Life Sciences is seeking experienced English into Lithuanian linguists specializing in Medical Devices and In Vitro Diagnostics translation.

You will translate and copy edit regulatory documentation, ensure accurate terminology, and comply with project‑specific quality requirements. The role requires memoQ12.5 proficiency and adherence to ISO‑certified workflows. Ongoing weekly availability is expected.